Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Trading Company
Tel: +86-371- 86259723
Tel: 17734809689
Tel: 17734809689
Tel: 86-371-86259723
Tel: 17734809689
Tel: 17734809689
Mobile: 17734809689
Tel: +86-371- 86259723
Fax: +86-371- 86259723
Province/state: HENAN
City: ZHENGZHOU
Street: Mingmen International Center, NO.222 Dongming Road,Zhengzhou,Henan,China
MaxCard:
CAS NO.179324-69-7
1(10-100)Metric Ton1(10-100)Metric Ton
Tech Data Relevant
1.Certificate Of Analysis (COA)
2..Material Safety Data Sheet (MSDS)
3.Technical Data Sheet(TDS)
4.Route of synthesis (ROS)
5.Nuclear Magnetic Resonance(NMR)
6.Method of Analysis(MOA)
Our Service
1. Before Shipment.
Quality control, Packing pictures and loading video before loading.
2. Shipment.
Prompt shipment with professional documents, Mixed containers with different mixed items in one container.
3. After shipment.
Strong after-sale service.
Exhibition in Shanghai
We have clients throughout the world:
Professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet your desire.
Our Laboratory
We have our own independent lab test center:
This makes sure that our technology support is reliable and authoritative. All of self-owned fine chemicals are manufactured strictly in accordance with international standard, and also has scientific cooperation with local colleges and institutes.
Our Factory
High quality with competitive price:
We are manufacturer and can provide high quality products with factory price.
Package & Shipment
Fast and safe delivery:
Parcels can be sent out within 24 hours after payment, and Tracking Number is available.
And you have various choices of transportation methods.
PRODUCT INFORMATION :
C19H25BN4O4
Bortezomib Basic information |
Drug for Cancer treatment |
Product Name: | Bortezomib |
Synonyms: | VELCADE;dpba;BORTEZOMIB;[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid;VELCADE(BORTEZOMIB);Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;Bortezomib for research;Bortezomib ( Velcade, MG-341, PS-341 ) |
CAS: | 179324-69-7 |
MF: | C19H25BN4O4 |
MW: | 384.24 |
EINECS: | |
Product Categories: | Boron Derivatives;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;Pepetides;ProteasomeInhibitors;Apis;Inhibitor;Final material;API;peptides |
Mol File: | 179324-69-7.mol |
Bortezomib Chemical Properties |
mp | 122-124°C |
density | 1.214 |
storage temp. | Hygroscopic, -20°C Freezer, Under Inert Atmosphere |
Stability: | Hygroscopic and Moisture Sensitive |
CAS DataBase Reference | 179324-69-7(CAS DataBase Reference) |
Safety Information |
Hazardous Substances Data | 179324-69-7(Hazardous Substances Data) |
Bortezomib Usage And Synthesis |
Drug for Cancer treatment |
Bortezomib is a drug for treatment of hematopoietic malignancies with the appearance being white or white-like crystalline powder. It is easily soluble in dimethyl sulfoxide, ethanol, but insoluble in aqueous solution. This product is the reversible inhibitor of the mammal cell 26S proteasome chymotrypsin-like activity. 26S proteasome is a large protein complex which can degrade ubiquitin. Ubiquitin proteasome pathway plays an important role in regulation of the intracellular concentration of specific proteins in order to maintain the stability of the intracellular environment. Proteolytic affects intracellular multi-level signalling cascade. The disruption of the normal intracellular environment can lead to cell death while the inhibition of the 26S proteasome can prevent the hydrolysis of specific proteins. In vitro tests have proved bortezomib exhibits cytotoxicity to multiple types of cancer cells. The in vivo models of preclinical tumor have proved that bortezomib is capable of delaying the tumor growth of multiple myeloma which is suitable for the treatment of multiple myeloma. The above information is edited by the Chemicalbook of Dai Xiongfeng. |
Chemical Properties | Yellow Solid |
Usage | Bortezomib is the first proteasome inhibitor to be approved b the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. T |
Usage | Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle foun d in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway. |
Usage | selective proteasome inhibitor |
COMPANY INFORMATION :
HenNan sunlake enterprise corporation is located in Henan Province , The central plain of China , Which enjoys favorable geogeaphical position and convenient transportion, The com[any was established in june. 1998 , until now having more than 18 years experience in manufacturing & exporting chemical raw material .